Results 191 to 200 of about 2,290,618 (347)

Assessment of Sedative Activity of Lonicerin: In Vivo Approach With Pharmacokinetics and Molecular Docking

open access: yesBrain and Behavior, Volume 15, Issue 5, May 2025.
Lonicerin (LON) at doses of 5 and 10 mg/kg reduced sleep latency and increased sleep duration in mice, with combined LON and diazepam showing maximal effects. Computational docking showed LON binds to GABAA receptor sites with a strong affinity (−8.1 kcal/mol), suggesting potential as an insomnia treatment. ABSTRACT Background: Lonicerin (LON) has been
Tanzila Akter Eity   +7 more
wiley   +1 more source

Progress in GABAA receptor agonists for insomnia disorder. [PDF]

open access: yesFront Pharmacol
Wang W   +5 more
europepmc   +1 more source

Role of Glutamate Excitotoxicity in Glioblastoma Growth and Its Implications in Treatment

open access: yesCell Biology International, Volume 49, Issue 5, Page 421-434, May 2025.
ABSTRACT Glioblastoma is a highly malignant and invasive type of primary brain tumor that originates from astrocytes. Glutamate, a neurotransmitter in the brain plays a crucial role in excitotoxic cell death. Excessive glutamate triggers a pathological process known as glutamate excitotoxicity, leading to neuronal damage.
Colin Moriarty   +2 more
wiley   +1 more source

Astrocytes Mediate Psychostimulant‐Induced Alterations of Spike‐Timing Dependent Synaptic Plasticity

open access: yesGlia, Volume 73, Issue 5, Page 1051-1067, May 2025.
Main Points Cocaine and amphetamine stimulates astrocytes and downregulates the GLT‐1. The dysfunction in GLT‐1 modify EPSP kinetics and modulate STDP, switching LTP to LTD in psychostimulant‐treated mice. These effects were restored by upregulation of GLT‐1.
Samuel Alberquilla   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy